All samples·Sample analysis
Get your own pass — $199
granted.bioAll samples
Analysis

radioligand therapy for prostate cancer

Overview
  • Dashboard
Analysis
  • What Surprised Us
  • Field Maturity
  • Funding Landscape
  • Competitive Topology
  • White Space
  • Market Context
Data
  • Projects115
  • Clinical Trials500
  • Patents29
  • Publications646
  • Organizations52
  • Researchers125
Reference
  • Methodology
Back
radioligand therapy for prostate cancerOrganizationsDIVISION OF BASIC SCIENCES - NCI

DIVISION OF BASIC SCIENCES - NCI

Projects attributed to DIVISION OF BASIC SCIENCES - NCI within this analysis sample.

In This Analysis
Projects
7
NIH Funding
$12.4M
Projects(7)
ProjectPICategoryFunding
Prostate Cancer Imaging
ZIABC010655
CHOYKE, PETER L (contact)Therapeutics$3.9M
Targeting mechanisms of radiation resistance
ZIABC011552
CITRIN, DEBORAH (contact)Basic Research$3.6M
Radiopharmaceutical Imaging and Therapy of Cancer
ZIABC012167
CHOYKE, PETER L (contact)Basic Research$1.9M
Evaluation of novel treatments in biochemically recurrent prostate
ZIABC011896
MADAN, RAVI (contact)Therapeutics$1.2M
Vaccine and radiation for the therapy of human cancers
ZIABC010975
HODGE, JAMES (contact)Therapeutics$1.1M
Trials for Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
ZIABC012193
KARZAI, FATIMA (contact)Basic Research$411K
Improving PSMA-based radioligand therapy via combination radioligand therapy
ZIABC011895
LIN, FRANK (contact)Therapeutics$321K
See DIVISION OF BASIC SCIENCES - NCI’s full platform profile
Cross-source view across the entire granted.bio dataset — projects, trials, patents, and publications spanning every topic, not just this analysis.